Abstract
The significant advances achieved over the past decade in the field of percutaneous coronary intervention have significantly increased our ability to use catheter-based techniques to modify cardiac physiology. The ongoing studies demonstrating the significant potential of cell-based therapy for the prevention and treatment of chronic heart failure has led to the development of multiple catheter-based systems for the delivery of cells to the injured myocardium. Advances have also been made in catheter-based systems that exploit electomechanical properties of the heart in order to direct the interventionalist as to the best areas in which to inject cells. In this chapter we will review the different catheter systems currently available or under development as well as discuss how different features of each may be optimal in the different settings of acute myocardial infarction and chronic heart failure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005;102(32):11,474–11,479.
Chachques JC, Salanson-Lajos C, Lajos P, Shafy A, Alshamry, Carpentier A. Cellular cardiomyoplasty for myocardial regeneration. Asian Cardiovasc Thorac Ann 2005;13:287–296.
Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005;26:1188–1195.
Perin EC, Silva GV. Stem cell therapy for cardiac diseases. Curr Opin Hematol 2004;11:399–403.
Orlic D. BM stem cells and cardiac repair: where do we stand in 2004? Cytotherapy 2005;7:3–15.
Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751–756.
Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141–148.
Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107(18):2294–2302.
Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003;107:461–468.
Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002;105:2012–2018.
Gyongyosi M, Sochor H, Khorsand A, Gepstein L, Glogar D. Online myocardial viability assessment in the catheterization laboratory via NOGA electroanatomic mapping: quantitative comparison with thallium-201 uptake. Circulation 2001;104:1005–1011.
Lessick J, Kornowski R, Fuchs S, Ben Haim SA. Assessment of NOGA catheter stability during the entire cardiac cycle by means of a special needle-tipped catheter. Catheter Cardiovasc Interv 2001;52:400–406.
Corti R, Badimon J, Mizseif G, et al. Real time magnetic resonance guided endomyocardial local delivery. Heart 2005;91(3):348–353.
Gyongyosi M, Khorsand A, Sochor H, et al. Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping. Am J Cardiol 2005;95:722–728.
Gyongyosi M, Khorsand A, Zamini S, et al. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation 2005;112:I157–I165.
Karmarkar PV, Kraitchman DL, Izbudak I, et al. MR-trackable intramyocardial injection catheter. Magn Reson Med 2004;51:1163–1172.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Hook, M., Whitlow, P. (2007). Aspects of Percutaneous Cellular Cardiomyoplasty. In: Penn, M.S. (eds) Stem Cells And Myocardial Regeneration. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-272-4_13
Download citation
DOI: https://doi.org/10.1007/978-1-59745-272-4_13
Publisher Name: Humana Press
Print ISBN: 978-1-58829-664-1
Online ISBN: 978-1-59745-272-4
eBook Packages: MedicineMedicine (R0)